Us Bancorp \De\ Uni Qure N.V. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Uni Qure N.V. stock. As of the latest transaction made, Us Bancorp \De\ holds 425 shares of QURE stock, worth $7,394. This represents 0.0% of its overall portfolio holdings.

Number of Shares

425

Previous 425 -0.0%

Holding current value

$7,394

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$4.39 - $5.43 $3,011 - $3,724	-686 Reduced 61.75%	425 $1,000
Q1 2024 May 07, 2024	BUY	$4.82 - $6.93 $2,048 - $2,945	425 Added 61.95%	1,111 $5,000
Q4 2023 Feb 09, 2024	SELL	$5.63 - $8.27 $12,070 - $17,730	-2,144 Reduced 75.76%	686 $4,000
Q3 2023 Nov 03, 2023	BUY	$6.71 - $11.83 $16,915 - $29,823	2,521 Added 815.86%	2,830 $18,000
Q2 2023 Aug 09, 2023	SELL	$11.12 - $22.2 $15,334 - $30,613	-1,379 Reduced 81.69%	309 $3,000
Q1 2023 May 09, 2023	BUY	$18.7 - $23.07 $486 - $599	26 Added 1.56%	1,688 $33,000
Q4 2022 Feb 13, 2023	SELL	$18.12 - $27.32 $217 - $327	-12 Reduced 0.72%	1,662 $37,000
Q3 2022 Oct 27, 2022	SELL	$16.98 - $25.54 $5,161 - $7,764	-304 Reduced 15.37%	1,674 $31,000
Q2 2022 Aug 01, 2022	BUY	$13.15 - $20.45 $13,518 - $21,022	1,028 Added 108.21%	1,978 $37,000
Q1 2022 May 11, 2022	BUY	$14.54 - $21.5 $5,103 - $7,546	351 Added 58.6%	950 $17,000
Q4 2021 Feb 11, 2022	BUY	$20.24 - $36.01 $7,853 - $13,971	388 Added 183.89%	599 $12,000
Q3 2021 Nov 10, 2021	BUY	$26.01 - $38.22 $2,601 - $3,822	100 Added 90.09%	211 $7,000
Q2 2021 Aug 05, 2021	SELL	$29.97 - $37.17 $479 - $594	-16 Reduced 12.6%	111 $3,000
Q1 2021 Apr 28, 2021	SELL	$29.24 - $42.03 $818 - $1,176	-28 Reduced 18.06%	127 $4,000
Q4 2020 Feb 04, 2021	BUY	$35.35 - $50.67 $5,479 - $7,853	155 New	155 $6,000
Q2 2020 Aug 07, 2020	SELL	$45.06 - $67.74 $5,181 - $7,790	-115 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$40.01 - $73.97 $64,336 - $118,943	-1,608 Reduced 93.33%	115 $5,000
Q4 2019 Feb 04, 2020	BUY	$37.13 - $74.62 $37,167 - $74,694	1,001 Added 138.64%	1,723 $123,000
Q3 2019 Nov 08, 2019	BUY	$39.36 - $76.8 $5,510 - $10,752	140 Added 24.05%	722 $29,000
Q2 2019 Aug 13, 2019	BUY	$52.76 - $82.19 $22,528 - $35,095	427 Added 275.48%	582 $46,000
Q1 2019 May 08, 2019	BUY	$27.39 - $68.41 $4,245 - $10,603	155 New	155 $9,000

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $813M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account